Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin's traditional 4-year halving cycle breaks as ETFs and institutional demand reshape price dynamics.

Market News
21 May 2026
Crypto news
View Source
Neutral
pluang ai news

Bitcoin's long-standing four-year halving cycle, which guided investor behavior for over a decade, has visibly broken in 2025-2026. The traditional pattern of price peaks 12-18 months post-halving no longer holds due to the overwhelming influence of institutional flows from spot Bitcoin ETFs, macroeconomic factors, and corporate treasury buying. These forces have replaced the supply shock effect of halving as the main price drivers, making the old cycle unreliable. Analysts are divided: some see the cycle as dead with a new, more stable regime emerging, while others believe it has merely stretched. Going forward, investors must monitor ETF flows, Federal Reserve policies, corporate buying, and regulation rather than rely on the halving clock alone, marking a maturation of Bitcoin as an asset class.

More News

ICF International sees 24% stock upside with 2026 growth driven by energy, AI, and federal projects.

ICF International sees 24% stock upside with 2026 growth driven by energy, AI, and federal projects.

Analyst Barrington raised ICF International's price target to $110, suggesting a 24.45% upside from $88.39. The company expects 3% revenue growth and 5% non-GAAP EPS growth in 2026, fueled by energy, AI, and federal modernization efforts. Q2 2026 ear...

Analyst Insights
Bullish
3 hours ago
HSBC upgrades YPF to Buy on strong Q2 results and $51B LNG expansion plan

HSBC upgrades YPF to Buy on strong Q2 results and $51B LNG expansion plan

HSBC has upgraded YPF's rating to Buy following strong Q2 2026 results, including a 41.7% revenue increase to $6.57 billion and earnings per share of $3.07, surpassing estimates. YPF raised its 2026 adjusted EBITDA guidance to $8 billion and aims for...

Analyst Insights
Bullish
3 hours ago
Vivos Therapeutics beats Q2 EPS estimates but misses revenue, faces liquidity concerns.

Vivos Therapeutics beats Q2 EPS estimates but misses revenue, faces liquidity concerns.

Vivos Therapeutics reported Q2 2026 earnings per share of -$0.31, beating analyst expectations of -$0.42, but its revenue of $5.15 million fell short of the $5.63 million estimate. The company, focused on sleep apnea treatments, sees growing patient ...

Company Fundamentals
Neutral
3 hours ago
Major stocks fall sharply amid mixed earnings and negative outlooks, signaling broader market concerns.

Major stocks fall sharply amid mixed earnings and negative outlooks, signaling broader market concerns.

Several leading stocks, including SoundThinking, TSS, and ADI Global Distribution, dropped significantly due to factors like lowered revenue forecasts and disappointing quarterly results. SoundThinking fell over 25% after cutting its revenue outlook ...

Market News
Bearish
3 hours ago
World Liberty Financial gets conditional OCC approval for national trust bank to manage USD1 stablecoin.

World Liberty Financial gets conditional OCC approval for national trust bank to manage USD1 stablecoin.

World Liberty Financial, linked to the Trump family, received preliminary conditional approval from the U.S. Office of the Comptroller of the Currency (OCC) to establish a national trust bank. This approval allows the company to bring issuance, redem...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App